Interaction Checker

Interacciones de Hialuronidasa

Hialuronidasa (Hylenex, Amphadase, Vitrase) tiene 106 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 12; moderadas: 78; leves: 16; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (12)

  • AdrenalinasimpaticomiméticoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Apraclonidinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Brimonidinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Brimonidina y timololagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Clonidinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Dexmedetomidinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Guanfacinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Lofexidinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • MetildopaantihipertensivoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Midodrinaagonista alfa-adrenérgicoGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Tizanidinarelajante muscularGrave

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • VincristinaGrave

    Local injection of hyaluronidase and the application of moderate heat to the area of leakage help disperse the drug and are thought to minimize discomfort and the possibility of cellulitis. (etiqueta de Vincristina, Advertencia en recuadro)

Interacciones moderadas (78)

  • Ácido acetilsalicílicoAINEModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Ácido acetilsalicílico y dipiridamolantiagregante plaquetarioModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Articaína y adrenalinaanestésico localModerada

    Admixture stability studies have shown that 2% lidocaine with 1:100,000 or 1:200,000 epinephrine is incompatible with hyaluronidase due to the presence of sodium metabisulfite, a common additive in anesthetic products containing epinephrine. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • AzelastinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Azelastina y fluticasonaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • BalsalazidasalicilatoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Bicarbonato de sodioantiácidoModerada

    Extravasation: Prompt elevation of the area, warmth, and local injection of lidocaine or hyaluronidase are recommended to reduce the likelihood of tissue sloughing at the site. (etiqueta de Bicarbonato de sodio, Advertencias y precauciones)

  • Bromfeniramina, pseudoefedrina y dextrometorfanoantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Bupivacaínaanestésico localModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Bupivacaína y adrenalinaanestésico localModerada

    Admixture stability studies have shown that 2% lidocaine with 1:100,000 or 1:200,000 epinephrine is incompatible with hyaluronidase due to the presence of sodium metabisulfite, a common additive in anesthetic products containing epinephrine. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Butalbital, ácido acetilsalicílico y cafeínabarbitúricoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Butalbital, ácido acetilsalicílico, cafeína y codeínabarbitúricoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • CarbinoxaminaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • CetirizinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • CiproheptadinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • ClemastinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • ClorfenaminaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Cloroprocaínaanestésico localModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Cocaínaanestésico localModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Desfluranoanestésico generalModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DesloratadinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Desogestrel y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DexclorfeniraminaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Diacetato de etinodiol y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DifenhidraminaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DiflunisalAINEModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DimenhidrinatoantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DoxilaminaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Doxilamina y piridoxinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Drospirenona y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • EstradiolestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Estradiol y dienogestanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Estradiol y noretisteronaestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Estrógenos conjugadosestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Estrógenos conjugados y bazedoxifenoestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Estrógenos esterificados y metiltestosteronaestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Etomidatoanestésico generalModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Etonogestrel y etinilestradiolestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • FexofenadinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • FulvestrantestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Hidrocodona y clorfenaminaopioideModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • HidroxizinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Isofluranoanestésico generalModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Ketaminadepresor del SNCModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • LevocetirizinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Levonorgestrel y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Levotiroxinahormona tiroideaModerada

    …recommended that appropriate references first be consulted to determine the usual precautions for the use of the other drug; e.g., when epinephrine is injected along with hyaluronidase, the precautions for the use of epinephrine in cardiovascular disease, thyroid disease, diabetes, digital nerve block, ischemia of the fingers and toes etc., should be observed. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Levotiroxina y liotironinahormona tiroideaModerada

    …recommended that appropriate references first be consulted to determine the usual precautions for the use of the other drug; e.g., when epinephrine is injected along with hyaluronidase, the precautions for the use of epinephrine in cardiovascular disease, thyroid disease, diabetes, digital nerve block, ischemia of the fingers and toes etc., should be observed. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Lidocaínaanestésico localModerada

    Admixture stability studies have shown that 2% lidocaine with 1:100,000 or 1:200,000 epinephrine is incompatible with hyaluronidase due to the presence of sodium metabisulfite, a common additive in anesthetic products containing epinephrine. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Lidocaína y adrenalinaanestésico localModerada

    Admixture stability studies have shown that 2% lidocaine with 1:100,000 or 1:200,000 epinephrine is incompatible with hyaluronidase due to the presence of sodium metabisulfite, a common additive in anesthetic products containing epinephrine. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Lidocaína y prilocaínaanestésico localModerada

    Admixture stability studies have shown that 2% lidocaine with 1:100,000 or 1:200,000 epinephrine is incompatible with hyaluronidase due to the presence of sodium metabisulfite, a common additive in anesthetic products containing epinephrine. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Liotironinahormona tiroideaModerada

    …recommended that appropriate references first be consulted to determine the usual precautions for the use of the other drug; e.g., when epinephrine is injected along with hyaluronidase, the precautions for the use of epinephrine in cardiovascular disease, thyroid disease, diabetes, digital nerve block, ischemia of the fingers and toes etc., should be observed. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • LoratadinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • MeclozinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Mentol y salicilato de metilosalicilatoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Mepivacaínaanestésico localModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • MesalazinasalicilatoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Metimazolfármaco antitiroideoModerada

    …recommended that appropriate references first be consulted to determine the usual precautions for the use of the other drug; e.g., when epinephrine is injected along with hyaluronidase, the precautions for the use of epinephrine in cardiovascular disease, thyroid disease, diabetes, digital nerve block, ischemia of the fingers and toes etc., should be observed. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • MetohexitalbarbitúricoModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Norelgestromina y etinilestradiolestrógenoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Noretisterona y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Norgestimato y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Norgestrel y etinilestradiolanticonceptivo oralModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • OlopatadinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Olopatadina y mometasonaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Orfenadrina, ácido acetilsalicílico y cafeínarelajante muscularModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Prilocaína y adrenalinaanestésico localModerada

    Admixture stability studies have shown that 2% lidocaine with 1:100,000 or 1:200,000 epinephrine is incompatible with hyaluronidase due to the presence of sodium metabisulfite, a common additive in anesthetic products containing epinephrine. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • PrometazinaantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Prometazina y codeínaopioideModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Prometazina y dextrometorfanoantihistamínicoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Propiltiouracilofármaco antitiroideoModerada

    …recommended that appropriate references first be consulted to determine the usual precautions for the use of the other drug; e.g., when epinephrine is injected along with hyaluronidase, the precautions for the use of epinephrine in cardiovascular disease, thyroid disease, diabetes, digital nerve block, ischemia of the fingers and toes etc., should be observed. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Propofoldepresor del SNCModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Ropivacaínaanestésico localModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • SalsalatoAINEModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Sevofluranoanestésico generalModerada

    • Local anesthetics: Hyaluronidase hastens onset and shortens duration of effect, increases incidence of systemic reactions ( 7.3 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Subsalicilato de bismutosalicilatoModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • SulfasalazinasulfonamidaModerada

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Teriparatidahormona tiroideaModerada

    …recommended that appropriate references first be consulted to determine the usual precautions for the use of the other drug; e.g., when epinephrine is injected along with hyaluronidase, the precautions for the use of epinephrine in cardiovascular disease, thyroid disease, diabetes, digital nerve block, ischemia of the fingers and toes etc., should be observed. (etiqueta de Hialuronidasa, Interacciones medicamentosas)

Menciones leves (16)

  • AlprazolambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • ClobazambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • ClonazepambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • ClorazepatobenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • ClordiazepóxidobenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Clordiazepóxido y clidiniobenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • DiazepambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • EstazolambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • FenitoínaanticonvulsivoLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • FlumazenilobenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • Furosemidadiurético de asaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • LorazepambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • MidazolambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • OxazepambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • TemazepambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

  • TriazolambenzodiazepinaLeve

    • Furosemide, the benzodiazepines and phenytoin are incompatible with hyaluronidase ( 7.1 ) (etiqueta de Hialuronidasa, Interacciones medicamentosas)

Compruebe Hialuronidasa frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.